3. As regard Gastric adenocarcinoma….
•1ST most common primary malignant tumor of the stomach is
GAC.
•2nd most common GIT tumor is GAC.
•3rd leading cause of cancer related death worldwide.
•5 year SR of GAC < 30%.
•30 % are metastatic at time of presentation.
11. HDGC
AD with early onset of diffuse GAC .
Mutation in CDH1 gene ( E-CADHERIN ).
1 – 3 % of gastric cancer .
Treated by prophylactic total gastrectomy .
13. Investigation
For diagnosis : endoscopy and biopsy ---- Barium meal.
for staging : CT triphasic---EUS ----PET..CT---Staging laparoscopy.
Preoperative assessment .
Follow up: CEA—CA19-9 -----CA 72.4
14. Management
Early GAC ( Tis or T1a ) : D1 gastrectomy and adjuvant CT.
Locally advanced GAC (T1b to T4 ) : NACT then surgery
followed by adjuvant CT .
Unresectable or metastatic : Palliative symptomatic care .
17. •Modified D2 lymphadenectomy is the standard of care
(NCCN 2018 ).
•Safety margin is 5 cm .
•Extent of lymphadenectomy is 15 LN or more .
•Most important prognostic factor depend on number of
LN not the anatomical distribution .